Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of remimazolam on neuromuscular transmission
jRCT1071230039Recruiting
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Open-label, single-arm trial of remimazolam, sponsored by none. Primary endpoints: Changes in TOF ratio after conversion from propofol to remimazolam and Changes in T1 response after conversion from propofol to remimazolam. Started Jul 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT1071230039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071230039.